Standard Life plc
24 July 2006
Not for release, publication or distribution, directly or indirectly, in or into
the United States, Australia or Japan.
STANDARD LIFE PLC (the 'Company')
The Company is pleased to announce that, as contemplated in connection with the
demutualisation and flotation transaction (the 'Transaction'), the following
reductions of capital were confirmed by the Court of Session on 21 July 2006:-
1. for the Company, a reduction of £500 million in its share premium account;
and
2. for Standard Life Assurance Limited ('SLAL'), the Company's principal
operating subsidiary, the cancellation of its entire share premium account.
The court orders making these reductions were each registered with the Registrar
of Companies on 21 July 2006 and are effective from that date.
As explained in the public documentation relating to the Transaction, the
Company initially had no distributable reserves but, as a result of the
reduction of its share premium account, the distributable reserves of the
Company will now be increased by £500 million. As also explained in that
documentation, the cancellation of the share premium account of SLAL removes a
possible restriction upon declaring and paying dividends to the Company out of
future surplus cashflows derived from the long term insurance business of SLAL.
These reductions in capital will therefore put in place the appropriate
structural arrangements, contemplated as part of the Transaction, to support the
Company's ability to pay dividends to its shareholders and to service debt.
24 July 2006
Enquiries:
Peter Tyson, Group Legal 0131 246 5717
Julie Reith, Group Secretariat 0131 245 6772
Scott White, Press Office 0131 245 5422
Barry Cameron, Press Office 0131 245 6165
This announcement does not constitute an offer of, or the solicitation of an
offer to buy or subscribe for, ordinary shares in the Company ( 'Ordinary Shares
') to any person in any jurisdiction to whom or in which jurisdiction such offer
or solicitation is unlawful and, in particular, is not for release, publication
or distribution in Australia or Japan.
The offer sale and/or issue of the Ordinary Shares has not been and will not be
registered under US Securities Act of 1933, as amended (the 'Securities Act') or
qualified for sale under the laws of any State of the United States or qualified
for distribution by prospectus in Canada or under any applicable securities laws
of Australia or Japan. Subject to certain exceptions, the Ordinary Shares may
not be offered, sold or delivered within Australia or Japan or the United States
or to or for the benefit of, any national, resident or citizen of Australia or
Japan. The Ordinary shares are being offered and sold within the United States
only to 'qualified institutional buyers' ('QIBs') (as defined in Rule 144A under
the US Securities Act ('Rule 144A')) and in reliance on Rule 144A or another
exception from, or in a transaction not subject to the registration requirements
of the US Securities Act and outside the United States in reliance on Regulation
S under the US Securities Act ('Regulation S'). The Ordinary Shares are being
distributed in Canada under exemptions from the prospectus filing requirements
of securities legislation in Canada.
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.